SCHEMBL20174301

SCHEMBL20174301

c1ccc(-c2cc(-c3cccc4c3-c3oc5ccccc5c3C43c4ccccc4-c4ccccc43)c3ccccc3n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 3/20 0.38
ACHE P22303 1/20 0.37
HPGD P15428 5/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 2/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE10A Q9Y233 1/20 0.35
ABCG2 Q9UNQ0 4/20 0.35
DHODH Q02127 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
ABCB1 P08183 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174247 0.89 ADORA3 (0.34) ACHEHPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL20174232 0.87 PDK2 (0.33) HPGDALDH1A1KDM4EMAPK1MAPT
SCHEMBL20174212 0.87 KMT2A (0.33) ACACAHPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL20174275 0.85 KMT2A (0.32) HPGDLMNAALDH1A1KDM4EMAPK1
SCHEMBL20174263 0.85 KMT2A (0.36) ACACAHPGDLMNAALDH1A1KDM4E
SCHEMBL20174424 0.84 ACACA (0.38) ACACAACHEHPGDLMNASMN1; SMN2
SCHEMBL20174206 0.84 MAPT (0.35) HPGDLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL20174351 0.83 ACACA (0.37) ACACAACHEHPGDLMNASMN1; SMN2
SCHEMBL20174297 0.83 ACACA (0.42) ACACAACHEHPGDLMNASMN1; SMN2
SCHEMBL24647394 0.82 ACHE (0.45) ACACAACHEHPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG ACACA 2815/4885ACHE 2816/4885HPGD 2229/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG ACACA 2815/4885ACHE 2816/4885HPGD 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.